ImmuneBiotech AB - a microbiome company uniquely placed to develop therapeutically effective probiotic products designed using scientific and pharmacologic methods. Our products are scientifically designed combinations of safe probiotic strains. We have a technology platform to select and combine lactobacilli strains to have impact on important pathological alterations, such as: gut microbial dysbiosis, intestinal permeability and mucosal/systemic inflammation. We have access to a library of 150 unique probiotic strains as a base for designing powerful probiotic products. GutMagnific GutMagnific is our first product, scientifically designed for Irritable Bowel Syndrome (IBS) with market launch as a food supplement in 2019. GutMagnific is a patent pending multi-strain combination of probiotic lactobacilli strains. GutMagnificTM is expected to be effective on several gut related symptoms including IBS, Myalgic Encephalomyelitis also called Chronic Fatigue Syndrome (ME/CFS), and Clostridium difficile infection (CDI). GutMagnificTM is the only multi-targeted probiotic product designed to address the three most important hallmarks underlying biological mechanisms of these indications.